Exchange Traded Concepts LLC Sells 630 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Exchange Traded Concepts LLC reduced its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 75.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 201 shares of the medical instruments supplier’s stock after selling 630 shares during the period. Exchange Traded Concepts LLC’s holdings in West Pharmaceutical Services were worth $60,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Findlay Park Partners LLP boosted its holdings in West Pharmaceutical Services by 30.6% in the 1st quarter. Findlay Park Partners LLP now owns 597,106 shares of the medical instruments supplier’s stock valued at $236,281,000 after purchasing an additional 139,800 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of West Pharmaceutical Services by 6.8% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 593,692 shares of the medical instruments supplier’s stock worth $195,556,000 after purchasing an additional 37,702 shares in the last quarter. ProShare Advisors LLC increased its position in shares of West Pharmaceutical Services by 13.9% in the first quarter. ProShare Advisors LLC now owns 500,662 shares of the medical instruments supplier’s stock worth $198,117,000 after purchasing an additional 61,247 shares during the last quarter. Sei Investments Co. raised its stake in West Pharmaceutical Services by 12.7% in the second quarter. Sei Investments Co. now owns 401,026 shares of the medical instruments supplier’s stock valued at $132,095,000 after purchasing an additional 45,208 shares in the last quarter. Finally, Envestnet Asset Management Inc. lifted its position in West Pharmaceutical Services by 9.8% during the second quarter. Envestnet Asset Management Inc. now owns 301,339 shares of the medical instruments supplier’s stock valued at $99,258,000 after purchasing an additional 26,947 shares during the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Price Performance

Shares of NYSE:WST opened at $286.44 on Thursday. The company’s fifty day moving average price is $299.72 and its 200-day moving average price is $323.06. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.34 and a quick ratio of 1.68. The firm has a market capitalization of $20.87 billion, a price-to-earnings ratio of 37.79, a PEG ratio of 10.46 and a beta of 1.01. West Pharmaceutical Services, Inc. has a one year low of $265.00 and a one year high of $413.70.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The company had revenue of $702.10 million during the quarter, compared to analysts’ expectations of $729.36 million. During the same quarter last year, the firm posted $2.11 earnings per share. The firm’s revenue was down 6.9% on a year-over-year basis. On average, equities research analysts anticipate that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current fiscal year.

Insider Transactions at West Pharmaceutical Services

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the completion of the sale, the vice president now owns 1,478 shares of the company’s stock, valued at $443,400. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.53% of the company’s stock.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.